Therapeutic efficacy assessment of weak variable magnetic fields with low value of induction in patients with drug-resistant depression

Journal of Affective Disorders

Volumn 123, Issue 1-3, 2010, Pages 321-326

  Sobiś, Jarosław ^a   Jarzab, Magdalena ^a   Hese, Robert Teodor ^a   Sieroń, Aleksander ^a   Zyss, Tomasz ^b   Gorczyca, Piotr ^a   Gierlotka, Zbigniew ^a   Pudlo, Robert ^a   Matysiakiewicz, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Drug resistant depression; Therapy; Weak variable magnetic fields

Indexed keywords

FLUVOXAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAGNETIC FIELD; MAGNETIC STIMULATION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77952102481     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.09.016     Document Type: Article

References (40)

1. Avery D.H., Holtzheimer III P.E., Fawaz W., Russo J., Neumaier J., Dunner D.L., Haynor D.R., Claypoole K.H., Wajdik C., and Roy-Byrne P. Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study. J. Nerv. Ment. Dis. 195 5 (2007) 378-381
2. Avery D.H., Isenberg K.E., Sampson S.M., Janicak P.G., Lisanby S.H., Maixner D.F., Loo C., Thase M.E., Demitrack M.A., and George M.S. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J. Clin. Psychiatry 69 3 (2008) 441-451
3. Bao X., Shi Y., Huo X., and Song T. A possible involvement of beta-endorphin, substance P, and serotonin in rat analgesia induced by extremely low frequency magnetic field. Bioelectromagnetics 27 6 (2006) 467-472
4. Beale I.L., Pearce N.E., Conroy D.M., Henning M.A., and Murrell K.A. Psychological effects of chronic exposure to 50 Hz magnetic fields in humans living near extra-high-voltage transmission lines. Bioelectromagnetics 18 8 (1997) 584-594
5. Brakemeier E.L., Wilbertz G., Rodax S., nker-Hopfe H., Zinka B., Zwanzger P., Grossheinrich N., Varkuti B., Rupprecht R., Bajbouj M., and Padberg F. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. J. Affect. Disord. 108 1-2 (2008) 59-70
6. Bretlau L.G., Lunde M., Lindberg L., Unden M., Dissing S., and Bech P. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry 41 2 (2008) 41-47
7. Carlezon Jr. W.A., Rohan M.L., Mague S.D., Meloni E.G., Parsegian A., Cayetano K., Tomasiewicz H.C., Rouse E.D., Cohen B.M., and Renshaw P.F. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol. Psychiatry 57 6 (2005) 571-576
8. Carpenter L.L. Neurostimulation in resistant depression. J. Psychopharmacol. 20 3 Suppl (2006) 35-40
9. Dell'Osso B., Mundo E., D'Urso N., Pozzoli S., Buoli M., Ciabatti M., Rosanova M., Massimini M., Bellina V., Mariotti M., and Altamura A.C. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord. 11 1 (2009) 76-81
10. Ebmeier K.P., and Herrmann L.L. TMS-the beginning of the end or the end of the beginning?. Psychol. Med. 38 3 (2008) 319-321
11. Eitan R., and Lerer B. Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin. Neurosci. 8 2 (2006) 241-258
12. Fregni F., Marcolin M.A., Myczkowski M., Amiaz R., Hasey G., Rumi D.O., Rosa M., Rigonatti S.P., Camprodon J., Walpoth M., Heaslip J., Grunhaus L., Hausmann A., and Pascual-Leone A. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 9 6 (2006) 641-654
13. Garcia-Toro M., Salva J., Daumal J., Andres J., Romera M., Lafau O., Echevarria M., Mestre M., Bosch C., Collado C., Ibarra O., and Aguirre I. High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res. 146 1 (2006) 53-57
14. Golfert F., Hofer A., Thummler M., Bauer H., and Funk R.H. Extremely low frequency electromagnetic fields and heat shock can increase microvesicle motility in astrocytes. Bioelectromagnetics 22 2 (2001) 71-78
15. Janicak P.G., O'Reardon J.P., Sampson S.M., Husain M.M., Lisanby S.H., Rado J.T., Heart K.L., and Demitrack M.A. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J. Clin. Psychiatry 69 2 (2008) 222-232
16. Lopez-Ibor J.J., Lopez-Ibor M.I., and Pastrana J.I. Transcranial magnetic stimulation. Curr. Opin. Psychiatry 21 6 (2008) 640-644
17. Lyskov E.B., Juutilainen J., Jousmaki V., Partanen J., Medvedev S., and Hanninen O. Effects of 45-Hz magnetic fields on the functional state of the human brain. Bioelectromagnetics 14 2 (1993) 87-95
18. Marangell L.B., Martinez M., Jurdi R.A., and Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr. Scand. 116 3 (2007) 174-181
19. Massot O., Grimaldi B., Bailly J.M., Kochanek M., Deschamps F., Lambrozo J., and Fillion G. Magnetic field desensitizes 5-HT(1B) receptor in brain: pharmacological and functional studies. Brain Res. 858 1 (2000) 143-150
20. O'Reardon J.P., Blumner K.H., Peshek A.D., Pradilla R.R., and Pimiento P.C. Long-term maintenance therapy for major depressive disorder with rTMS. J. Clin. Psychiatry 66 12 (2005) 1524-1528
21. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D., Fitzgerald P.B., Loo C., Demitrack M.A., George M.S., and Sackeim H.A. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry 62 11 (2007) 1208-1216
22. Ossenkopp K.P., and Ossenkopp M.D. Geophysical variables and behavior: XI. Open-field behaviors in young rats exposed to an elf rotating magnetic field. Psychol. Rep. 52 2 (1983) 343-349
23. Rakofsky J.J., Holtzheimer P.E., and Nemeroff C.B. Emerging targets for antidepressant therapies. Curr. Opin. Chem. Biol. 3 3 (2009) 291-302
24. Repetitive transcranial magnetic stimulation (TMS) for medication-resistant depression: Med Lett Drugs Ther 2009; 51(1305):11-12.
25. Rossini D., Lucca A., Zanardi R., Magri L., and Smeraldi E. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial. Psychiatry Res. 137 1-2 (2005) 1-10
26. Rossini D., Magri L., Lucca A., Giordani S., Smeraldi E., and Zanardi R. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J. Clin. Psychiatry 66 12 (2005) 1569-1575
27. Rudolph K., Krauchi K., Wirz-Justice A., and Feer H. Weak 50-Hz electromagnetic fields activate rat open field behavior. Physiol. Behav. 35 4 (1985) 505-508
28. Sandyk R. The effects of external picotesla range magnetic fields on the EEG in Parkinson's disease: a follow up study. Int. J. Neurosci. 76 3-4 (1994) 227-229
29. Sandyk R. Alzheimer's disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields. Int. J. Neurosci. 76 3-4 (1994) 185-225
30. Sandyk R. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. Int. J. Neurosci. 83 1-2 (1995) 45-57
31. Shah D.B., Weaver L., and O'Reardon J.P. Transcranial magnetic stimulation: a device intended for the psychiatrist's office, but what is its future clinical role?. Expert Rev. Med. Devices 5 5 (2008) 559-566
32. Sherman R.A., Robson L., and Marden L.A. Initial exploration of pulsing electromagnetic fields for treatment of migraine. Headache 38 3 (1998) 208-213
33. Sieron A., Labus L., Nowak P., Cieslar G., Brus H., Durczok A., Zagzil T., Kostrzewa R.M., and Brus R. Alternating extremely low frequency magnetic field increases turnover of dopamine and serotonin in rat frontal cortex. Bioelectromagnetics 25 6 (2004) 426-430
34. Simpson K.N., Welch M.J., Kozel F.A., Demitrack M.A., and Nahas Z. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv. Ther. 26 3 (2009) 346-368
35. Stern W.M., Tormos J.M., Press D.Z., Pearlman C., and Pascual-Leone A. Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. J. Neuropsychiatry Clin. Neurosci. 19 2 (2007) 179-186
36. Wang M., Guo M., Wang X., Ma S., and Liu B. Study on effect and mechanism of magnetic fields simulating EEG rhythm upon memory. Conf. Proc. IEEE Eng. Med. Biol. Soc. 6 (2004) 4451-4453
37. Whissell P.D., and Persinger M.A. Emerging synergisms between drugs and physiologically-patterned weak magnetic fields: implications for neuropharmacology and the human population in the twenty-first century. Curr. Neuropharmacol. 5 4 (2007) 278-288
38. Wrobel M.P., Szymborska-Kajanek A., Wystrychowski G., Biniszkiewicz T., Sieron-Stoltny K., Sieron A., Pierzchala K., Grzeszczak W., and Strojek K. Impact of low frequency pulsed magnetic fields on pain intensity, quality of life and sleep disturbances in patients with painful diabetic polyneuropathy. Diabetes Metab. 34 4 Pt 1 (2008) 349-354
39. Zyss T. Magnetotherapy. Neuro Endocrinol. Lett. 29 Suppl 1 (2008) 161-201
40. Zyss T., Mamczarz J., Roman A., and Vetulani J. Comparison of effectiveness of two schedules of rapid transcranial magnetic stimulation on enhancement of responsiveness to apomorphine. Pol. J. Pharmacol. 51 4 (1999) 363-366